Post-Market Study in China
|Evomela (melphalan) For Injection||Multiple Melanoma||To evaluate the efficacy and safety of Evomela for maintenance treatment of Multiple Melanoma|
Upcoming Clinical Trials
|CID-103||Multiple Melanoma||To evaluate the efficacy and safety of CID-103 for treatment of Multiple Melanoma|
For more information on trials conducted by our partners for CNCT19 and BI-1206, please refer to clinicaltrials.gov.